We aimed to evaluate the mRNA expression of VISTA, Galectin-9, and TIM-3 on CD8+ T-cells and leukemic cells in B-cell acute lymphoblastic leukemia (B-ALL). This evidence concerns the gene HAVCR2 and B-cell acute lymphoblastic leukemia.